Lumos Pharma enters merger agreement with Double Point Ventures to go private
PremiumThe FlyLumos Pharma enters merger agreement with Double Point Ventures to go private
20d ago
Lumos Pharma initiated with a Buy at EF Hutton
Premium
The Fly
Lumos Pharma initiated with a Buy at EF Hutton
2M ago
Lumos Pharma reports Q2 EPS (93c), consensus ($1.24)
Premium
The Fly
Lumos Pharma reports Q2 EPS (93c), consensus ($1.24)
3M ago
Is LUMO a Buy, Before Earnings?
PremiumPre-EarningsIs LUMO a Buy, Before Earnings?
7M ago
Lumos Pharma receives notice of allowance from USPTO for LUM-201 patent
Premium
The Fly
Lumos Pharma receives notice of allowance from USPTO for LUM-201 patent
8M ago
Lumos Pharma reports Q4 EPS ($1.17), consensus ($1.15)
Premium
The Fly
Lumos Pharma reports Q4 EPS ($1.17), consensus ($1.15)
8M ago
Lumos Pharma announces new data, analysis of patient from OraGrowtH212 trial
PremiumThe FlyLumos Pharma announces new data, analysis of patient from OraGrowtH212 trial
1y ago
Lumos Pharma price target lowered to $10 from $14 at Cantor Fitzgerald
Premium
The Fly
Lumos Pharma price target lowered to $10 from $14 at Cantor Fitzgerald
1y ago
Is LUMO a Buy, Before Earnings?
Premium
Pre-Earnings
Is LUMO a Buy, Before Earnings?
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100